The cAMP response element (CRE) is an octanucleotide motif (TGACGTCA) that mediates diverse transcriptional regulatory effects. In this report we describe the isolation and characterization of a full-length cDNA that encodes a CRE binding protein called CREB-2. Like other ATF/CREB transcription factors, the 351-amino acid CREB-2 protein contains a COOH-terminal leucine-zipper motif and an adjacent basic domain. CREB-2 mRNA is expressed ubiquitously in human tumor cell lines and mouse organs suggesting that it is involved in regulating transcription in a wide variety ofcell types. Overexpression ofCREB-2 resulted in a consistent and si t repression of CRE-dependent transcription in CV-1 cells. Deletional analyses localized the transcriptional repressor activity of CREB-2 to a 102-ami acid COOHterminal region (amino acids 249-351) that contains the leucine-zipper and basic domains of the molecule. These results demonstrate that CRE-dependent transcription can be both positively and negatively regulated by structurally related members of the ATF/CREB family.
The transcription of many eukaryotic genes is regulated by the binding of sequence-specific transcription factors to modular cis-acting promoter and enhancer elements. The cAMP response element (CRE) is among the best studied of the cis-acting transcriptional enhancer motifs. This palindromic octanucleotide (TGACGTCA) has been identified (1) (2) (3) (4) (5) in the transcriptional regulatory regions of a large number of eukaryotic genes and has been shown to mediate diverse transcriptional effects including (i) conferring responsiveness to cAMP (1, 2) ; (ii) binding a cellular factor, ATF, and thereby conferring Ela responsiveness on several adenovirus genes (3) ; and (iii) modulating the basal activity of eukaryotic transcriptional enhancers including the human T-cell leukemia virus type I (4) and the c-fos protooncogene enhancers (5) .
Recent studies have resulted in the cloning of several CRE binding proteins that form the ATF/CREB family (6) (7) (8) (9) (10) (11) .
These proteins share highly related COOH-terminal leucinezipper dimerization and basic DNA binding domains, but each contains a distinct NH2-terminal region. Although each of the ATF/CREB proteins appears to be capable of binding to the CRE as a homodimer, some of these proteins also bind to DNA as heterodimers (6, 8, 9) . One of these proteins, CREB, has been shown to be a transcriptional activator that requires phosphorylation by protein kinase A (PKA) for its activity (12) . A second protein, CRE-BP1 (also called HB16 and ATF-2) (6, 9, 10) binds to CRE sites as a heterodimer in conjunction with the JUN protein (9) and also interacts with the adenovirus Ela protein to activate transcription from CRE sites (13) . Although a number of additional ATF/CREB proteins have been cloned (6) , many ofthese clones represent partial-length cDNAs, and the transcriptional activities of most of these proteins remain unknown.
In this report we describe the isolation and characterization of a cDNA clone that encodes an ubiquitously expressed CRE-binding protein that (14) have been described. The pCH110 (15) and pMSVfBgal (16) (18) of the CREB-2 cDNA with the synthetic oligonucleotide primers 5' primer (CCA AGC TTA TGG ATC CTC CTG GAG AGA AGA TGG) and 3' primer (GCC TCG AGA AGC ACA TTG ACG CTC CTG AC).
DNase I Footprint Analysis. DNase I footprint analyses were performed as described (19) .
Electrophoretic-Mobility-Shift Assay (EMSA). An EMSA using Jurkat nuclear extracts or Agtll or 6A2 crude lysogen extracts was performed as described (19) A Agtll Jurkat T-cell cDNA library was screened for CREbinding proteins using a radiolabeled Tal probe as described (24) .
DNA Sequencing. DNA sequence analysis was performed by the dideoxynucleotide chain-termination method.
Northern Blot Analysis. RNA prepared from human tumor cell lines (25) and from mouse organs (18) was subjected to Northern blot analysis using a radiolabeled CREB-2 cDNA probe (26) .
Transfections and CAT Assays. Monkey CV-1 cells (106 cells per 100-mm dish) were transfected with calcium phosphate (18) . One to 5 ,ug of a 8-galactosidase containing reference plasmid (either pCH11O or pMSV/3gal) was included in each transfection. Cell extracts equalized for protein content were used for CAT and f3-galactosidase assays (19) .
Preparation of CREB-2-Specific Antiserum. Rabbit anti-CREB-2 antiserum was prepared by three sequential immunizations with 10 ttg of immunoaffinity-purified CREB-2-f3-galactosidase fusion protein (26) . This serum immunoprecipitated in vitro-translated CREB-2 protein but failed to immunoprecipitate CREB or CRE-BP1 proteins (data not shown). CREB-specific antiserum was the generous gift of Mark Montminy (The Salk Institute, La Jolla, CA).
RESULTS
The Tal Site of the Human T-Cell Receptor a Chain (TCRa) Enhancer Contains a CRE. We (20) and others (27) have identified and characterized a T-cell-specific transcriptional enhancer element located 4.5 kilobases (kb) 3' of the a chain constant region gene in the human and murine TCRa loci. The minimal TCRa enhancer contains two nuclear protein binding sites, Tal and Ta2, both of which are necessary for basal enhancer activity (20) . The Tal binding site contains a consensus CRE, TGACGTCA (1, 2) . Similar CRE motifs have been identified in the promoter regions of all murine and human TCR 8 chain variable region genes (28) and in the minimal TCR/3 transcriptional enhancer (29) . These TCR,8 promoter and enhancer CREs bind a set of nuclear proteins that is identical to that bound by the Tal element ofthe TCRa enhancer (29) .
The human TCRa enhancer CRE motif (Tal) was protected from DNase I digestion by both Jurkat T-cell and K562 chronic myelogenous leukemia cell nuclear proteins (Fig.  1A ). An EMSA using a radiolabeled Tal oligonucleotide and Jurkat nuclear extracts demonstrated at least three specific protein-DNA complexes of altered mobility (Fig. 1B , arrows). These complexes represented specific binding of nuclear proteins to the CRE motif because they were efficiently competed by both the wild-type unlabeled Tal competitor and by an unlabeled competitor containing the CRE from the human somatostatin gene (SOM) but not by mutant Tal (mTal) or somatostatin competitors containing nucleotide substitutions within the CRE motifs of these elements (Fig. 1B) . Moreover, the formation of these complexes was inhibited efficiently by CRE sequence motifs from the adenovirus E2 promoter and, to a lesser extent, by the CRE-like motifs from the human c-fos (Fig. 1B) and human T-cell leukemia virus type 1 promoters (data not shown) but not by the closely related AP-1 oligonucleotide from the collagenase promoter (Fig. 1B) . Finally, the pattern of nuclear protein binding to a radiolabeled somatostatin promoter CRE motif was identical to that seen using the radiolabeled Tal oligonucleotide (Fig. 1C ). Thus these results demonstrated that Jurkat T cells contain several CRE binding activities. Molecular Cloning of CREB-2 cDNAs. A cDNA expression approach (23) was used to isolate CREB cDNAs from a Agtll cDNA library prepared from Jurkat T-cell poly(A)+ RNA. One clone, 6A2, was identified that specifically bound multimerized radiolabeled Tal probe. This clone also bound a multimerized somatostatin CRE probe but not probes containing mutated CREs. To examine the specificity of binding of the recombinant fusion protein produced by this clone, lysogen extracts were used in an EMSA with radiolabeled Tal and somatostatin CRE probes. With both probes, the 6A2 lysogen extract produced a band of altered mobility that was not seen in control experiments using Agtll lysogen extracts (Fig. 2) . This band was competed specifically by excess unlabeled Tal (Fig. 2 A and C) and somatostatin ( Fig.  2 B and C) CRE sites but not by mutated CRE binding sites (mTal or mSOM; Fig. 2 A and C and data not shown) or by the consensus AP-1 oligonucleotide (Fig. 2B) . Thus, the 6A2 cDNA encodes a fusion protein that binds specifically to the CREs in both the TCRa enhancer and the somatostatin promoter. We have designated this cDNA CREB-2.
CREB-2 Contains Leucine-Zipper and Basic Domains but Lacks PKA and Protein Kinase C (PKC) Phosphorylation Sites. The 6A2 cDNA was used as a hybridization probe to identify a 1.4-kb cDNA clone approximating the size of the CREB-2 mRNA (1.5 kb) (see Fig. 4 ). This full-length CREB-2 cDNA contains a single long open reading frame of 1053 nucleotides and encodes a 351-amino acid protein of predicted molecular mass = 38.5 kDa (Fig. 3A) . The COOH- terminal end of the predicted CREB-2 protein contains a leucine-zipper motif and an adjacent basic domain that have been shown to be involved in the dimerization and DNA binding, respectively, of a number of other transcriptional regulatory proteins including c-fos, c-jun, several jun-and fos-related proteins-CEBP (30) (31) (32) (33) , CREB (7, 11) , CRE-BP1 (also called HB16 and ATF-2) (6, 9, 10), and ATFs 1 to 6(6). Of note, the amino acid sequence ofthe COOH-terminal region of CREB-2 is identical to that predicted from the partial-length cDNA, ATF-4 (6). However, because only the amino acid sequence of a partial-length ATF-4 cDNA has been reported, it is impossible to conclude definitively that these two cDNAs are identical. Unlike CREB and CRE-BP1, the NH2-terminal region of CREB-2 lacks potential PKA and PKC phosphorylation sites.
CREB-2 Is Expressed Ubiquitously in Tumor Cell Lines and Mouse Organs. Northern blot analyses using RNA derived from a variety of human tumor cell lines and normal mouse organs demonstrated that a single 1.5-kb CREB-2 transcript was expressed at high levels in all of the tumor cell lines studied (Fig. 4A) . In addition, the Epstein-Barr virustransformed B-cell line clone 13 contained a 1.2-kb CREB-2 bp mRNA. The structure of this second transcript remains unclear. CREB-2 mRNA was also detected in all ofthe mouse organs assayed (Fig. 4B) .
Overexpression of CREB-2 Represses CRE-Dependent Transcription. To better understand the transcriptional activity of the CREB-2 protein, we constructed eukaryotic expression vectors containing the CREB, CREB-2, and PKA catalytic subunit cDNAs (Fig. 5A) . These vectors were used to overexpress the relevant proteins after transfection into cAMP-responsive monkey CV-1 cells. The pENKAT-12 plasmid in which CAT transcription is under the control of the CRE-containing human enkephalin promoter (Fig. 5A ) was included in each transfection as a reporter for CREdependent transcription. Indirect immunofluorescence analyses of cells transfected with CREB and CREB-2 vectors demonstrated that (i) both CREB and CREB-2 are expressed at relatively low levels in the nuclei of untransfected CV-1 A set oftransient transfections was performed to determine the effects of overexpression of CREB and CREB-2 on CRE-dependent transcription in these cells. Transfection of the pENKAT-12 reporter plasmid alone resulted in low-level CAT activity that was normalized to a value of 1 (Fig. SB) . Overexpression of PKA increased CAT transcription by 39-fold. This finding, which apparently reflects the activation of endogenous CREB proteins by PKA, was consistent with previous experiments that have demonstrated that the enkephalin promoter is cAMP-responsive and that this responsiveness is mediated by the activation of PKA (14) . Overexpression of CREB in conjunction with PKA caused a further 4-fold increase in CRE-dependent transcription (Fig. SB) . This increase was specific for the enkephalin promoter and not simply the result of a generalized increase in transcription because overexpression of CREB had no effect on transcription from the cotransfected pMSV,8gal and pCH110 ,3-galactosidase reference plasmids. These results were in accord with previous studies that have demonstrated that CREB is a transcriptional activator that requires phosphorylation by PKA for its activity (12) .
In contrast to the results observed after overexpression of CREB, overexpression of CREB-2 in conjunction with PKA suppressed CAT transcription back to baseline levels (i.e., to levels similar to those produced by transfection with pENKAT-12 alone; Fig. SB (Fig. 5B ).
DISCUSSION
The studies described in this report have identified and characterized an ATF/CREB family member, CREB-2. CREB-2 is related to, but distinct from, the previously described CREB and CRE-BP1 proteins but may be identical to ATF-4. Although all of the ATF/CREB proteins including CREB-2 share highly related basic and leucine-zipper domains, CREB-2 lacks the PKA and PKC phosphorylation sites and the a-helical transcriptional activator domain found in the NH2 terminus of CREB. Unlike What is the physiological role of CREB-2 in regulating CRE-dependent transcription? Because it is expressed ubiquitously, it may serve the general function of preventing "leaky" transcription from CRE-containing promoters until appropriate levels of phosphorylated CREB (or other CREB activator proteins) have been generated in response to elevations ofintracellular cAMP. In addition, because CREs can modulate basal levels of transcription in a cAMPindependent fashion, CREB-2 might represent a negative regulator of cAMP-independent CRE-mediated transcription, similar to the recently described CREM transcription factor (34) . The availability of structurally and functionally characterized full-length ATF/CREB cDNA clones should facilitate future studies aimed at better understanding the interaction of these proteins and their roles in regulating cAMP-dependent and -independent gene expression.
